Business Development - Nutrition and Wellness

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

Nutrition and Wellness (N&W) Commercial team is a high performance, fun team focused on expanding Ginkgo’s synthetic biology platform in the Human and Animal Nutrition & Wellness field. We move fast and are a team of self starters who are passionate about our purpose and biased towards action towards growing our partnerships and business.

As a Manager/Associate Director/ Director/Senior Director of Business Development for Commercial Cell Engineering - Nutrition and Wellness (N&W), you will be a core part of the N&W Business Development team at Ginkgo. You will be scouting new areas where Ginkgo’s platform can effectively serve as a disruptive technology. Given your industry experience, you know the key players, understand the biotechnology field, keep up with emerging trends, and you can leverage your strong network to create an effective market strategy and sales pipeline. You also enjoy building relationships and teams and take a proactive approach to maximizing new and existing business opportunities. In your capacity as Director of Business Development, you will work with a cross-functional team comprising deal transaction, IP, legal, and technical program teams throughout all aspects of the proposal, negotiations and contract execution. And most importantly, you see the bigger picture: you’re excited about Ginkgo and eager to help us achieve our mission of making biology easier to engineer.

To learn more about Ginkgo, check out some recent press:

What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)

Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)

Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)

Ginkgo Raises $70 Million to Tackle Covid-19 Testing (Bloomberg)

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response (PR Newswire)

How to Test Every American for COVID-19, Every Day (The Atlantic)

The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)

The engineering of living organisms could soon start changing everything (The Economist)

Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)

Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)

Ginkgo Bioworks Is Turning Human Cells into On-Demand Factories (WIRED)

Can This Company Convince You to Love GMOs? (The Atlantic)

We also feel that it’s important to point out the obvious here – there’s a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.

We’re developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can – and will – impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it’s something we’ll be proud of as it continues to grow. Therefore, it’s critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.

It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees and employment applicants.